Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024

Abstract There is a significant gap in data regarding the survival time and the factors influencing the survival of people living with HIV (PLWH) undergoing antiretroviral therapy (ART) in Henan Province, a region severely impacted by the AIDS epidemic.Investigating survival and influencing factors...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Deng, Qiong Li, Zhihui Zhang, Zhaoyun Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-05821-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403211201380352
author Meng Deng
Qiong Li
Zhihui Zhang
Zhaoyun Chen
author_facet Meng Deng
Qiong Li
Zhihui Zhang
Zhaoyun Chen
author_sort Meng Deng
collection DOAJ
description Abstract There is a significant gap in data regarding the survival time and the factors influencing the survival of people living with HIV (PLWH) undergoing antiretroviral therapy (ART) in Henan Province, a region severely impacted by the AIDS epidemic.Investigating survival and influencing factors after ART can provide valuable insights to enhance patient management strategies and improve the prognosis for PLWH.This retrospective cohort study compiled case data and follow-up records of PLWH receiving ART at the Infectious Disease Hospital of Henan Province between 2004 and 2024. Survival curves were generated using the Kaplan-Meier method, and both univariate and multivariate Cox proportional hazards models were employed to identify factors influencing survival outcomes. Among the 4,307 study participants, a total of 251 (5.83%) patients died. The overall cumulative survival rate to the observation endpoint was 80%. The multifactorial Cox proportional risk regression modeling analysis of the primary outcomes showed that patients aged > 60 years at diagnosis of HIV/AIDS (HR = 4.706, 95% CI: 2.175 ~ 10.180), transmission route of heterosexual (HR = 1.403, 95% CI: 1.021 ~ 1.928) and blood transmission (HR = 1.855, 95% CI:1.206 ~ 2.855), patients with CD4+ T cell count < 200cells/µL (HR = 1.636,95% CI: 1.136 ~ 2.354) had a higher risk of death. Our findings highlight the importance of targeted ART management for high-risk populations, such as older individuals, heterosexual or blood-borne transmission and those with low CD4+ T cell count, to further improve survival outcomes and optimize HIV/AIDS treatment strategies.
format Article
id doaj-art-7afbabfb18eb4a39b38748be967bfd34
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-7afbabfb18eb4a39b38748be967bfd342025-08-20T03:37:20ZengNature PortfolioScientific Reports2045-23222025-07-011511810.1038/s41598-025-05821-4Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024Meng Deng0Qiong Li1Zhihui Zhang2Zhaoyun Chen3Henan Clinical Research Center of Infectious Diseases (AIDS), Affiliated Infectious Diseases Hospital of Zhengzhou University, Henan Infectious Diseases HospitalHenan Clinical Research Center of Infectious Diseases (AIDS), Affiliated Infectious Diseases Hospital of Zhengzhou University, Henan Infectious Diseases HospitalHenan Clinical Research Center of Infectious Diseases (AIDS), Affiliated Infectious Diseases Hospital of Zhengzhou University, Henan Infectious Diseases HospitalHenan Clinical Research Center of Infectious Diseases (AIDS), Affiliated Infectious Diseases Hospital of Zhengzhou University, Henan Infectious Diseases HospitalAbstract There is a significant gap in data regarding the survival time and the factors influencing the survival of people living with HIV (PLWH) undergoing antiretroviral therapy (ART) in Henan Province, a region severely impacted by the AIDS epidemic.Investigating survival and influencing factors after ART can provide valuable insights to enhance patient management strategies and improve the prognosis for PLWH.This retrospective cohort study compiled case data and follow-up records of PLWH receiving ART at the Infectious Disease Hospital of Henan Province between 2004 and 2024. Survival curves were generated using the Kaplan-Meier method, and both univariate and multivariate Cox proportional hazards models were employed to identify factors influencing survival outcomes. Among the 4,307 study participants, a total of 251 (5.83%) patients died. The overall cumulative survival rate to the observation endpoint was 80%. The multifactorial Cox proportional risk regression modeling analysis of the primary outcomes showed that patients aged > 60 years at diagnosis of HIV/AIDS (HR = 4.706, 95% CI: 2.175 ~ 10.180), transmission route of heterosexual (HR = 1.403, 95% CI: 1.021 ~ 1.928) and blood transmission (HR = 1.855, 95% CI:1.206 ~ 2.855), patients with CD4+ T cell count < 200cells/µL (HR = 1.636,95% CI: 1.136 ~ 2.354) had a higher risk of death. Our findings highlight the importance of targeted ART management for high-risk populations, such as older individuals, heterosexual or blood-borne transmission and those with low CD4+ T cell count, to further improve survival outcomes and optimize HIV/AIDS treatment strategies.https://doi.org/10.1038/s41598-025-05821-4Human immunodeficiency virusAcquired immunodeficiency syndromeAntiretroviral therapySurvival analysis
spellingShingle Meng Deng
Qiong Li
Zhihui Zhang
Zhaoyun Chen
Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
Scientific Reports
Human immunodeficiency virus
Acquired immunodeficiency syndrome
Antiretroviral therapy
Survival analysis
title Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
title_full Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
title_fullStr Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
title_full_unstemmed Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
title_short Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024
title_sort survival analysis of plwh on antiretroviral therapy in henan province from 2004 to 2024
topic Human immunodeficiency virus
Acquired immunodeficiency syndrome
Antiretroviral therapy
Survival analysis
url https://doi.org/10.1038/s41598-025-05821-4
work_keys_str_mv AT mengdeng survivalanalysisofplwhonantiretroviraltherapyinhenanprovincefrom2004to2024
AT qiongli survivalanalysisofplwhonantiretroviraltherapyinhenanprovincefrom2004to2024
AT zhihuizhang survivalanalysisofplwhonantiretroviraltherapyinhenanprovincefrom2004to2024
AT zhaoyunchen survivalanalysisofplwhonantiretroviraltherapyinhenanprovincefrom2004to2024